Effectiveness of shorter femoral stems for hip replacement surgery, testing the biomechanics, using computer simulations, and comparing clinical outcomes between two types of short stems: one with a collar and one without
ISRCTN | ISRCTN12375281 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN12375281 |
Secondary identifying numbers | 26646 |
- Submission date
- 30/04/2024
- Registration date
- 15/05/2024
- Last edited
- 04/06/2024
- Recruitment status
- Recruiting
- Overall study status
- Ongoing
- Condition category
- Surgery
Plain English Summary
Background and study aims
Hip osteoarthritis, a condition increasingly prevalent in the Western world, causes significant suffering for affected individuals. Total hip arthroplasty, a surgical procedure to replace the damaged hip joint, stands as one of the most successful interventions in modern medicine, providing relief from pain for patients. Advances in techniques and technology have widened the accessibility of hip replacement surgery, allowing more patients, even those at younger ages, to benefit from it.
However, this trend has led to a growing need for revising the initial hip replacements as they wear out over time. This presents a challenge that will only become more pronounced in the future. Newer femoral stems, designed to be shorter in length and attach closer to the top of the thigh bone (proximal femoral metaphysis), aim to preserve bone stock and can be implanted without cement, potentially simplifying revision surgeries.
The goal of this research is to compare two types of these short femoral stems: one with a collar and one without. We hypothesize that the collared femoral stem will demonstrate better stability, in terms of both microstability (small-scale movement) and subsidence (sinking into the bone), leading to improved clinical outcomes for patients.
Who can participate?
Patients aged 50 - 80 years requiring a hip replacement.
What does the study involve?
Participants will be randomly allocated to receive the collared femoral stem or the non-collared femoral stem as part of their hip replacement surgery. Follow-up will be for 24 months.
What are the possible benefits and risks of participating?
Added benefits for the patient would be the close monitoring with the treating physician before and for 2 years after the surgery. Follow-up clinical scores will give the opportunity to the patient to discuss the problems they are facing and find solutions with their physician. Gait analysis will help investigate possible functional deficits.
No added risks for the patient are associated with the current study. The only drawbacks are the additional transports for the patient in order to perform the follow-ups, at the benefit of close physician monitoring.
Where is the study run from?
University General Hospital of Patras (Greece)
When is the study starting and how long is it expected to run for?
September 2023 to January 2030
Who is funding the study?
University General Hospital of Patras (Greece)
Who is the main contact?
Dr Vasileios Giannatos, vasileiosgiannatos@outlook.com
Contact information
Public, Scientific, Principal Investigator
Leykosias 48
Patras
26441
Greece
0000-0002-8599-9604 | |
Phone | +30 6945608508 |
vasileiosgiannatos@outlook.com |
Scientific
Leykosias 48
Patras
26441
Greece
andpan21@gmail.com |
Scientific
Leykosias 48
Patras
26441
Greece
irinitatani@gmail.com |
Study information
Study design | Randomized prospective study |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Hospital, University/medical school/dental school |
Study type | Treatment |
Participant information sheet | Not available in web format, please use the contact details to request a participant information sheet. Send an email to vasileiosgiannatos@outlook.com or irinitatani@gmail.com or communicate via phone at +306945608508 |
Scientific title | Short metaphyseal-fitting femoral stems in primary total hip arthroplasty: biomechanical testing, finite element analysis and randomized-prospective comparative clinical study of a collared and a non-collared short stem |
Study hypothesis | The collared femoral stem will show superior stability in terms of microstability and subsidence and thus better clinical outcomes regarding patient reported outcomes and gait analysis. Regarding the biomechanical study, our hypothesis is that biomechanical testing and finite element analysis will reveal less subsidence for the collared stem. |
Ethics approval(s) |
Approved 18/01/2024, University General Hospital of Patras Ethics Committee (Rion, Patras, 26504, Greece; +30 2610 997245; achaidop@pgnp.gr), ref: 26646 |
Condition | Total hip arthroplasty for hip osteoarthritis |
Intervention | Total hip arthroplasty will be performed in patients with hip osteoarthritis and no hip surgery on the other side or hip dysplasia. The two stems compared will be a short-collared stem and a short stem. Participants are randomized using Random.org. Clinically, our data will be collected prospectively including patient-reported outcomes questionnaires (HOOS, Harris Hip Score, SF12, VAS), nutritional indexes, biochemical studies, clinical tests (Time Up and Go, 6m Walk Test), hand grip test and gait analysis pre- and postoperatively according to the literature. As far as the radiological results are concerned, a standard anteroposterior pelvis x-ray will be performed pre-operatively and at 3, 6, 12 and 24 months postoperatively, as well as a CT scan preoperatively. Regarding the biomechanical part, a finite element analysis model will be developed and the behavior of the two stems implanted will be modeled. A biomechanical experiment will be set utilizing a loading device to load composite implanted Sawbones under normal circumstances. Inductive miniature displacement transducers and digital image correlation will be used to measure subsidence and stress shielding accordingly. The data from the biomechanical experiment will be used to verify the finitel element analysis model. The verified model will be used to study the behaviour of the two stems regarding the stems’ subsidence and strain distribution (stress shielding). An interdisciplinary team of statisticians and clinicians will discuss and correlate the results of the biomechanical and clinical study. |
Intervention type | Procedure/Surgery |
Primary outcome measure | 1. Patient-reported outcomes reported preoperatively and at 3, 6, 12 and 24 months using: 1.1. Hip pain and function measured using Forgoten Joint Score 12 (FJS-12) 1.2. Hip pain and function measured using Hip Disability and Osteoarthritis Outcome Score (HOOS) 1.3. Hip pain and function measured using Harris Hip Score (HHS) 1.4. Pain measured using Visual Analogue Scale (VAS) 2. Quality of life measured using Western Ontario and McMaster Universities Arthritis Index (WOMAC) and 12-Item Short Form Health Survey (SF-12) preoperatively and at 3, 6, 12 and 24 months 3. Stem subsidence measured using anteroposterior pelvis x-ray at 1, 3, 6 and 12 months |
Secondary outcome measures | 1. Gait analysis using VICON 2.4 preoperatively and at 1 and 6 months postoperatively 2. Handgrip strength measured using a Jamar Hydraulic Hand Dynamometer at 3 max repetitions and capturing the best effort preoperatively |
Overall study start date | 01/09/2023 |
Overall study end date | 01/01/2030 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Lower age limit | 50 Years |
Upper age limit | 80 Years |
Sex | Both |
Target number of participants | 160 |
Participant inclusion criteria | 1. Age 50 - 80 years old 2. Primary hip osteoarthritis 3. Inflammatory hip arthritis 4. Hip avascular necrosis 5. Post-traumatic arthritis |
Participant exclusion criteria | 1. Inability to participate 2. Hip anatomy that inhibits short stem fitting (Dorr C etc) 3. Active or recent infection 4. BMI >45 kg/m² 5. History of hip surgery 6. Commorbidities that would influence the final outcome (e.g. ankylosing spondylitis, neuromuscular diseases) |
Recruitment start date | 20/01/2024 |
Recruitment end date | 01/01/2028 |
Locations
Countries of recruitment
- Greece
Study participating centre
Patras
26504
Greece
Sponsor information
Hospital/treatment centre
Patras University Campus
Rion, Patras
Pátrai
26504
Greece
Phone | +30 2613603504 |
---|---|
irinitatani@upatras.gr | |
Website | http://www.pgnp.gr/ |
https://ror.org/03c3d1v10 |
Funders
Funder type
Hospital/treatment centre
No information available
Results and Publications
Intention to publish date | 31/12/2029 |
---|---|
Individual participant data (IPD) Intention to share | Yes |
IPD sharing plan summary | Available on request |
Publication and dissemination plan | Planned publication in a peer-reviewed journal |
IPD sharing plan | The datasets generated during and/or analysed during the current study will be available upon request from Vasileios Giannatos (vasileiosgiannatos@outlook.com) |
Editorial Notes
04/06/2024: Two additional scientific contacts were added.
31/05/2024: Internal review.
13/05/2024: Study's existence confirmed by the University General Hospital of Patras Ethics Committee.